M&A Deal Summary |
|
---|---|
Date | 2022-08-03 |
Target | Curiosity Diagnostics |
Sector | Life Science |
Buyer(s) | Bio-Rad |
Sellers(s) | Scope Fluidics |
Deal Type | Divestiture |
Deal Value | 170M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1952 |
Sector | Medical Products |
Employees | 8,000 |
Revenue | 2.7B USD (2023) |
Bio-Rad is a developer, manufacturer, and marketer of a broad range of medical tools and services to the life science research and clinical diagnostics markets. Bio-Rad was incorporated in 1952 and is based in Hercules, California.
DEAL STATS | # |
---|---|
Overall | 8 of 8 |
Sector (Life Science) | 7 of 7 |
Type (Divestiture) | 2 of 2 |
Country (Poland) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-04-09 |
Celsee
Ann Arbor, Michigan, United States Celsee, Inc. offers instruments and consumables for the isolation, detection, and analysis of single cells. Celsee was founded in 2011 and is based in Ann Arbor, Michigan. |
Buy | - |
Scope Fluidics is a developer of innovative technological solutions for the medical diagnostics and healthcare markets through wholly owned limited liability companies. Scope Fluidics is developing the PCR|ONE technology for rapid, automated detection of infections via highly multiplexed PCR assays, and the BacterOMIC system for high-content automated antibiotic susceptibility testing. Scope Fluidics is based in Warsaw, Poland.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Poland) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 1 |